Quarterly report [Sections 13 or 15(d)]

Note 14 - Equity

v3.25.1
Note 14 - Equity
 3 Months Ended
Mar. 31, 2025
Notes to Financial Statements  
Equity [Text Block]

Note 14. Equity

 

Stock-based compensation expense is recorded in salaries, wages and payroll taxes expense in the Condensed Consolidated Statements of Comprehensive Loss. For the three months ended March 31, 2025 and 2024, stock-based compensation expense was approximately $7,000 and $0.6 million, respectively. The decrease in stock-based compensation was attributable to non-recurring grants fully vested. There were no income tax benefits recognized from stock-based compensation during the three months ended March 31, 2025 and 2024 due to cumulative losses and valuation allowances.

 

Preferred Stock

 

We have authorized 3,333,333 shares of $0.0001 par value of preferred stock. As of March 31, 2025 and  December 31, 2024 there were no shares of preferred stock issued and outstanding.

 

Common Stock

 

We have authorized 50,000,000 shares of $0.0001 par value common stock. As of March 31, 2025 and  December 31, 2024, 25,963,051 and 25,963,051 shares of common stock, respectively, were issued and outstanding.

 

Listing on the Nasdaq Capital Market

 

Our common stock and warrants are traded on the Nasdaq Capital Market under the symbols “NXPL” and “NXPLW,” respectively.